Description

Ajmalanium, 4-(3-(Diethylamino)-2-Hydroxypropyl)-17,21-Dihydroxy-, (17 R,21Alpha)-, Salt With (2R,3R)-2,3-Dihydroxybutanedioic Acid (1:1), Mo Nohydrate is a high-purity, complex organic salt primarily used as a key intermediate in advanced pharmaceutical synthesis. This compound is valued for its specific stereochemistry and functional groups, which are critical for the development of active pharmaceutical ingredients (APIs) with targeted biological activity. It is essential for research and development laboratories and production facilities in the pharmaceutical and fine chemical industries seeking reliable, high-quality building blocks for complex molecule construction.

Application

• Pharmaceutical Intermediate: Serves as a critical chiral building block in the multi-step synthesis of complex drug molecules, particularly in steroid-derived therapeutics.
• Research & Development: Used in medicinal chemistry for the discovery and optimization of new chemical entities, especially those targeting neurological or hormonal pathways.
• Process Chemistry: Employed in scale-up and process development for the commercial manufacturing of Active Pharmaceutical Ingredients (APIs).
• Reference Standard: Can be utilized as an analytical standard for quality control and method validation in pharmaceutical analysis.
• Biochemical Research: Applied in studies investigating enzyme interactions or receptor binding due to its specific structural features.

Basic Information

Product Name	Ajmalanium, 4-(3-(Diethylamino)-2-Hydroxypropyl)-17,21-Dihydroxy-, (17 R,21Alpha)-, Salt With (2R,3R)-2,3-Dihydroxybutanedioic Acid (1:1), Mo Nohydrate
CAS No.	53862-81-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Ajmalanium tartrate salt; 17,21-Dihydroxyajmalanium 4-(3-diethylamino-2-hydroxypropyl) tartrate; Ajmaline derivative tartrate; (17R,21α)-Ajmalanium, 4-[3-(diethylamino)-2-hydroxypropyl]-17,21-dihydroxy-, salt with (2R,3R)-2,3-dihydroxybutanedioic acid (1:1); Ajmalanium hydrogen tartrate; CAS 53862-81-0; Ajmalanium compound with L-tartaric acid
EINECS	Contact for details

Quality Control

Our Ajmalanium tartrate salt is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including chromatographic purity assays and identity confirmation, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) detailing specific batch results are provided and available upon request to support your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment to maintain stability and purity. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 2.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.